Skip to main content
Erschienen in: Journal of Anesthesia 5/2016

05.07.2016 | Original Article

Impact of aspirin use on morbidity and mortality in massively transfused cardiac surgery patients: a propensity score matched cohort study

verfasst von: Michael Mazzeffi, Samuel Galvagno, James S. Gammie, Kenichi Tanaka

Erschienen in: Journal of Anesthesia | Ausgabe 5/2016

Einloggen, um Zugang zu erhalten

Abstract

Purpose

Aspirin may prevent organ dysfunction in critically ill patients and mitigate transfusion associated acute lung injury. We hypothesized that aspirin use might be associated with decreased morbidity and mortality in massively transfused cardiac surgery patients.

Methods

A single center retrospective cohort study was performed using data from an 8.5-year period (2006–2014). Massive transfusion was defined as receiving at least 2400 ml (8 units) of red blood cell units intraoperatively. A propensity score model was created to account for the likelihood of receiving aspirin and matched pairs were identified using global optimal matching. The primary endpoint, in-hospital mortality, was compared between aspirin users and non-users. Secondary outcomes including: ICU hours, mechanical lung ventilation hours, prolonged mechanical lung ventilation (>24 h), pneumonia, stroke, acute renal failure, atrial fibrillation, deep sternal wound infection, and multiple organ dysfunction syndrome were also compared.

Results

Of 7492 cardiac surgery patients, 452 (6 %) were massively transfused and mortality was 30.6 %. There were 346 patients included in the matched cohort. No significant association was found between preoperative aspirin use and in-hospital mortality; absolute risk reduction with aspirin = 7.5 % (95 % CI −2.0 to 16.9 %, p = 0.12). Preoperative aspirin use was associated with fewer total mechanical lung ventilation hours (p = 0.02) and less prolonged mechanical lung ventilation; absolute risk reduction = 11.0 % (95 % CI 1.1–20.5 %, p = 0.02).

Conclusions

Preoperative aspirin use is not associated with decreased in-hospital mortality in massively transfused cardiac surgery patients, but may be associated with less mechanical lung ventilation time.
Literatur
1.
Zurück zum Zitat Turan A, Yang D, Bonilla A, Shiba A, Sessler DI, Saager L, Kurz A. Morbidity and mortality after massive transfusion in patients undergoing non-cardiac surgery. Can J Anaesth. 2013;60(8):761–70.CrossRefPubMed Turan A, Yang D, Bonilla A, Shiba A, Sessler DI, Saager L, Kurz A. Morbidity and mortality after massive transfusion in patients undergoing non-cardiac surgery. Can J Anaesth. 2013;60(8):761–70.CrossRefPubMed
2.
Zurück zum Zitat Ortmann E, Besser MW, Klein AA. Antifibrinolytic agents in current anaesthetic practice. Br J Anaesth. 2013;111:549–63.CrossRefPubMed Ortmann E, Besser MW, Klein AA. Antifibrinolytic agents in current anaesthetic practice. Br J Anaesth. 2013;111:549–63.CrossRefPubMed
3.
4.
Zurück zum Zitat Simmons J, Sikorski RA, Pittet JF. Tranxeamic acid: from trauma to routine perioperative use. Curr Opin Anestheiol. 2015;28:191–200.CrossRef Simmons J, Sikorski RA, Pittet JF. Tranxeamic acid: from trauma to routine perioperative use. Curr Opin Anestheiol. 2015;28:191–200.CrossRef
5.
Zurück zum Zitat Karkouti K, O’Farrell R, Yau TM, Beattie WS. Prediction of massive blood transfusion in cardiac surgery. Can J Anaesth. 2006;53(8):781–94.CrossRefPubMed Karkouti K, O’Farrell R, Yau TM, Beattie WS. Prediction of massive blood transfusion in cardiac surgery. Can J Anaesth. 2006;53(8):781–94.CrossRefPubMed
6.
Zurück zum Zitat Karkouti K, Wijeysundera DN, Yau TM, Beattie WS, Abdelnaem E, McCluskey SA. The independent association of massive blood loss with mortality in cardiac surgery. Transfusion. 2004;44(10):1453–62.CrossRefPubMed Karkouti K, Wijeysundera DN, Yau TM, Beattie WS, Abdelnaem E, McCluskey SA. The independent association of massive blood loss with mortality in cardiac surgery. Transfusion. 2004;44(10):1453–62.CrossRefPubMed
7.
Zurück zum Zitat de Christo Dorneles C, Bodanese LC, da Costa Guaragna JCV, Macagnan FE, de Christo Dorneles C, Coelho JC, Borges AP, Goldani MA, Petracco JB. The impact of blood transfusion on morbidity and mortality after cardiac surgery. Rev Bras Cir Cardiovasc. 2011;26(2):222–9.CrossRef de Christo Dorneles C, Bodanese LC, da Costa Guaragna JCV, Macagnan FE, de Christo Dorneles C, Coelho JC, Borges AP, Goldani MA, Petracco JB. The impact of blood transfusion on morbidity and mortality after cardiac surgery. Rev Bras Cir Cardiovasc. 2011;26(2):222–9.CrossRef
8.
Zurück zum Zitat Losche W, Boettel J, Kabisch B, Winning J, Claus RA, Bauer M. Do aspirin and other antiplatelet drugs reduce the mortality in critically ill patients. Thrombosis 2012;720254. Losche W, Boettel J, Kabisch B, Winning J, Claus RA, Bauer M. Do aspirin and other antiplatelet drugs reduce the mortality in critically ill patients. Thrombosis 2012;720254.
9.
Zurück zum Zitat Kor DJ, Erlich J, Gong M, Malinchoc M, Carter R, Gajic O, Talmor D. Association of pre-hospitalization aspirin therapy and acute lung injury: results of a multicenter international observational study of at-risk-patients. Crit Care Med. 2011;39(11):2393–400.CrossRefPubMedPubMedCentral Kor DJ, Erlich J, Gong M, Malinchoc M, Carter R, Gajic O, Talmor D. Association of pre-hospitalization aspirin therapy and acute lung injury: results of a multicenter international observational study of at-risk-patients. Crit Care Med. 2011;39(11):2393–400.CrossRefPubMedPubMedCentral
10.
Zurück zum Zitat Looney MR, Nguyen JX, Hu Y, VanZiffle JA, Lowell CA, Matthay MA. Platelet depletion and aspirin treatment protect mice in a two-event model of transfusion related acute lung injury. J Clin Invest. 2009;119(11):3450–61.PubMedPubMedCentral Looney MR, Nguyen JX, Hu Y, VanZiffle JA, Lowell CA, Matthay MA. Platelet depletion and aspirin treatment protect mice in a two-event model of transfusion related acute lung injury. J Clin Invest. 2009;119(11):3450–61.PubMedPubMedCentral
11.
Zurück zum Zitat Mazzeffi M, Kassa W, Gammie J, Tanaka K, Roman P, Zhan M, Griffith B, Rock P. Preoperative aspirin use and lung injury after aortic valve replacement surgery: a retrospective cohort study. Anesth Analg. 2015;121(2):271–7.CrossRefPubMed Mazzeffi M, Kassa W, Gammie J, Tanaka K, Roman P, Zhan M, Griffith B, Rock P. Preoperative aspirin use and lung injury after aortic valve replacement surgery: a retrospective cohort study. Anesth Analg. 2015;121(2):271–7.CrossRefPubMed
12.
Zurück zum Zitat Erez E, Erman A, Snir E, Raanani E, Abramov D, Sulkes J, Boner G, Vidne BA. Thromboxane production in human lung during cardiopulmonary bypass: beneficial effect of aspirin? Ann Thorac Surg. 1998;65(1):101–6.CrossRefPubMed Erez E, Erman A, Snir E, Raanani E, Abramov D, Sulkes J, Boner G, Vidne BA. Thromboxane production in human lung during cardiopulmonary bypass: beneficial effect of aspirin? Ann Thorac Surg. 1998;65(1):101–6.CrossRefPubMed
13.
Zurück zum Zitat Gerrah R, Elami A, Stamler A, Smirnov A, Stoeger Z. Preoperative aspirin administration improves oxygenation in patients undergoing coronary artery bypass grafting. Chest. 2005;127(5):1622–6.CrossRefPubMed Gerrah R, Elami A, Stamler A, Smirnov A, Stoeger Z. Preoperative aspirin administration improves oxygenation in patients undergoing coronary artery bypass grafting. Chest. 2005;127(5):1622–6.CrossRefPubMed
14.
Zurück zum Zitat Goldhammer JE, Marhefka GD, Daskalakis C, Berguson MW, Bowen JE, Diehl JT, Sun J. The effect of aspirin on bleeding and transfusion in contemporary cardiac surgery. PLoS ONE. 2015;10(7):e0134670.CrossRefPubMedPubMedCentral Goldhammer JE, Marhefka GD, Daskalakis C, Berguson MW, Bowen JE, Diehl JT, Sun J. The effect of aspirin on bleeding and transfusion in contemporary cardiac surgery. PLoS ONE. 2015;10(7):e0134670.CrossRefPubMedPubMedCentral
15.
Zurück zum Zitat Alghamdi AA, Moussa F, Fremes SE. Does the use of preoperative aspirin increase the risk of bleeding in patients undergoing coronary artery bypass grafting surgery? Systematic review and meta-analysis. J Card Surg. 2007;22(3):247–56.CrossRefPubMed Alghamdi AA, Moussa F, Fremes SE. Does the use of preoperative aspirin increase the risk of bleeding in patients undergoing coronary artery bypass grafting surgery? Systematic review and meta-analysis. J Card Surg. 2007;22(3):247–56.CrossRefPubMed
16.
Zurück zum Zitat POISE-2 investigators: aspirin in patients undergoing noncardiac surgery. New Engl J Med 2014;370:1494–1503. POISE-2 investigators: aspirin in patients undergoing noncardiac surgery. New Engl J Med 2014;370:1494–1503.
17.
Zurück zum Zitat Austin PC. An introduction to propensity score methods for reducing the effects of confounding in observational studies. Multivariate Behav Res. 2011;46(3):399–424.CrossRefPubMedPubMedCentral Austin PC. An introduction to propensity score methods for reducing the effects of confounding in observational studies. Multivariate Behav Res. 2011;46(3):399–424.CrossRefPubMedPubMedCentral
18.
Zurück zum Zitat Garrido MM, Kelley AS, Paris J, Roza K, Meier DE, Morrison RS, Aldridge MD. Methods for constructing and assessing propensity scores. Health Serv Res. 2014;49(5):1701–20.CrossRefPubMedPubMedCentral Garrido MM, Kelley AS, Paris J, Roza K, Meier DE, Morrison RS, Aldridge MD. Methods for constructing and assessing propensity scores. Health Serv Res. 2014;49(5):1701–20.CrossRefPubMedPubMedCentral
19.
Zurück zum Zitat D’Agostino RB. Propensity scores in cardiovascular research. Circulation. 2007;115:2340–3.CrossRefPubMed D’Agostino RB. Propensity scores in cardiovascular research. Circulation. 2007;115:2340–3.CrossRefPubMed
20.
Zurück zum Zitat Coca-Perraillon M. Local and global optimal propensity score matching. SAS global forum, statistics and data analysis 2007:1–9. Coca-Perraillon M. Local and global optimal propensity score matching. SAS global forum, statistics and data analysis 2007:1–9.
21.
Zurück zum Zitat Holcolmb J, del Junco DJ, Fox EE, Wade CE, Cohen MJ, Schreiber MA, Alarcon LH, Bai Y, Brasel KJ, Bulger EM, Cotton BA, Matijevic N, Muskat P, Myers JG, Phelan HA, White CE, Zhang J, Rahbar MH. The prospective observational multicenter major trauma transfusion (PROMMTT) study: comparative effectiveness of a time-varying treatment with competing risks. JAMA Surg. 2013;148(2):127–36.CrossRef Holcolmb J, del Junco DJ, Fox EE, Wade CE, Cohen MJ, Schreiber MA, Alarcon LH, Bai Y, Brasel KJ, Bulger EM, Cotton BA, Matijevic N, Muskat P, Myers JG, Phelan HA, White CE, Zhang J, Rahbar MH. The prospective observational multicenter major trauma transfusion (PROMMTT) study: comparative effectiveness of a time-varying treatment with competing risks. JAMA Surg. 2013;148(2):127–36.CrossRef
22.
Zurück zum Zitat Borgman MA, Spinella PC, Holcolmb JB, Blackbourne LH, Wade CE, Lefering R, Bouillon B, Maegele M. The effect of FFP:RBC ratio on morbidity and mortality in trauma patients based on transfusion prediction score. Vox Sang. 2011;101(1):44–54.CrossRefPubMedPubMedCentral Borgman MA, Spinella PC, Holcolmb JB, Blackbourne LH, Wade CE, Lefering R, Bouillon B, Maegele M. The effect of FFP:RBC ratio on morbidity and mortality in trauma patients based on transfusion prediction score. Vox Sang. 2011;101(1):44–54.CrossRefPubMedPubMedCentral
23.
Zurück zum Zitat PROPRR Study Group. Transfusion of plasma, platelets, and red blood cells in a 1:1:1 vs. a 1:1:2 ratio and mortality in patients with severe trauma: the PROPRR randomized clinical trial. JAMA. 2015;313(5):471–82.CrossRef PROPRR Study Group. Transfusion of plasma, platelets, and red blood cells in a 1:1:1 vs. a 1:1:2 ratio and mortality in patients with severe trauma: the PROPRR randomized clinical trial. JAMA. 2015;313(5):471–82.CrossRef
24.
Zurück zum Zitat Neuman R, Hayek S, Rahman A, Poole JC, Menon V, Sher S, Newman JL, Karatela S, Polhemus D, Lefer DJ, De Staercke C, Hooper C, Quyyumi AA, Roback JD. Effects of storage-aged red blood cell transfusions on endothelial function in hospitalized patients. Transfusion. 2014;55(4):782–90.PubMedPubMedCentral Neuman R, Hayek S, Rahman A, Poole JC, Menon V, Sher S, Newman JL, Karatela S, Polhemus D, Lefer DJ, De Staercke C, Hooper C, Quyyumi AA, Roback JD. Effects of storage-aged red blood cell transfusions on endothelial function in hospitalized patients. Transfusion. 2014;55(4):782–90.PubMedPubMedCentral
25.
Zurück zum Zitat Roback JD. Vascular effects of the red blood cell storage lesion. Hematology Am Soc Hematol Educ Program 2011;475–9. Roback JD. Vascular effects of the red blood cell storage lesion. Hematology Am Soc Hematol Educ Program 2011;475–9.
26.
Zurück zum Zitat Taubert D, Berkels R, Grosser N, Schroder H, Grundemann D, Schomig E. Aspirin induces nitric oxide release from vascular endothelium: a novel mechanism of action. Br J Pharmacol. 2004;143(1):159–65.CrossRefPubMedPubMedCentral Taubert D, Berkels R, Grosser N, Schroder H, Grundemann D, Schomig E. Aspirin induces nitric oxide release from vascular endothelium: a novel mechanism of action. Br J Pharmacol. 2004;143(1):159–65.CrossRefPubMedPubMedCentral
27.
Zurück zum Zitat Passacquale G, Phinikaridou A, Warboys C, Cooper M, Lavin B, Alfieri A, Andia ME, Botnar RM, Ferro A. Aspirin induced histone acetylation in endothelial cells enhances synthesis of the secreted isoform of netrin-1 thus inhibiting monocyte vascular infiltration. Brit J Pharm. 2015;172:3548–64.CrossRef Passacquale G, Phinikaridou A, Warboys C, Cooper M, Lavin B, Alfieri A, Andia ME, Botnar RM, Ferro A. Aspirin induced histone acetylation in endothelial cells enhances synthesis of the secreted isoform of netrin-1 thus inhibiting monocyte vascular infiltration. Brit J Pharm. 2015;172:3548–64.CrossRef
28.
Zurück zum Zitat Umscheid CA, Kohl BA, Williams K. Antifibrinolytic use in adult cardiac surgery. Curr Opin Hematol. 2007;14:455–67.CrossRefPubMed Umscheid CA, Kohl BA, Williams K. Antifibrinolytic use in adult cardiac surgery. Curr Opin Hematol. 2007;14:455–67.CrossRefPubMed
29.
Zurück zum Zitat Zangrillo A, Mizzi A, Biondi-Zoccai G, Bignami E, Calabro MG, Pappalardo F, Dedola E, Tritapepe L, Marino G, Landoni G. Recombinant activated factor VII in cardiac surgery: a meta-analysis. J Cardiothorac Vasc Anesth. 2009;23(1):34–40.CrossRefPubMed Zangrillo A, Mizzi A, Biondi-Zoccai G, Bignami E, Calabro MG, Pappalardo F, Dedola E, Tritapepe L, Marino G, Landoni G. Recombinant activated factor VII in cardiac surgery: a meta-analysis. J Cardiothorac Vasc Anesth. 2009;23(1):34–40.CrossRefPubMed
30.
Zurück zum Zitat Levi M, Levy JH, Andersen HF, Truloff DT. Safety of recombinant activated factor VII in randomized clinical trials. N Engl J Med. 2010;363:1791–800.CrossRefPubMed Levi M, Levy JH, Andersen HF, Truloff DT. Safety of recombinant activated factor VII in randomized clinical trials. N Engl J Med. 2010;363:1791–800.CrossRefPubMed
31.
Zurück zum Zitat McIlroy DR, Myles PS, Phillips LE, Smith JA. Antifibrinolytics in cardiac surgical patients receiving aspirin: a systematic review and meta-analysis. Br J Anaesth. 2009;102(2):168–78.CrossRefPubMed McIlroy DR, Myles PS, Phillips LE, Smith JA. Antifibrinolytics in cardiac surgical patients receiving aspirin: a systematic review and meta-analysis. Br J Anaesth. 2009;102(2):168–78.CrossRefPubMed
Metadaten
Titel
Impact of aspirin use on morbidity and mortality in massively transfused cardiac surgery patients: a propensity score matched cohort study
verfasst von
Michael Mazzeffi
Samuel Galvagno
James S. Gammie
Kenichi Tanaka
Publikationsdatum
05.07.2016
Verlag
Springer Japan
Erschienen in
Journal of Anesthesia / Ausgabe 5/2016
Print ISSN: 0913-8668
Elektronische ISSN: 1438-8359
DOI
https://doi.org/10.1007/s00540-016-2213-2

Weitere Artikel der Ausgabe 5/2016

Journal of Anesthesia 5/2016 Zur Ausgabe

Update AINS

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.